Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Castaigne

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
Nouvelle Revue Francaise D'Hematologie|January 1, 1989
Treatment of multiple myeloma by high dose chemotherapy, total body irradiation and autologous blood stem cell autograftJ P Fermand, Y Lévy, J Gerota, et al.
Blood|January 1, 1989
Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graftJ P Fermand, Y Levy, J Gerota, et al.
Blood|November 1, 1992
All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 casesP Fenaux, S Castaigne, H Dombret, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
[Autografts of blood cells at various stages]S Castaigne, L Dal Cortivo, G Leverger, et al.
Nouvelle Revue Francaise D'Hematologie|July 1, 1994
[Role of double induction in the treatment of acute myeloblastic leukemia in the adult: intermediate results of protocol LAM90]S Castaigne, E Archimbaud, P Fenaux, et al.
Blood|July 15, 1994
Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL GroupP Fenaux, E Wattel, E Archimbaud, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Prognostic factors of acute non lymphoblastic leukemia in children and adults. Results from two multicentric trials (705 patients)S Castaigne, S Chevret, E Lepage, et al.
Leukemia & Lymphoma|February 1, 1995
Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL GroupP Fenaux, C Chastang, C Chomienne, et al.
Haematology and Blood Transfusion|January 1, 1990
Comparison of chemotherapy and autologous and allogeneic transplantation as postinduction regimen in adult acute lymphoblastic leukemia: a preliminary multicentric studyD Fiere, A Broustet, V Leblond, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1987
Alpha-interferon in hairy cell leukaemia: direct effects on hairy cells or indirect cytotoxicity?F Sigaux, S Castaigne, P Lehn, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Nouvelle Revue Francaise D'Hematologie|January 1, 1989
Treatment of multiple myeloma by high dose chemotherapy, total body irradiation and autologous blood stem cell autograftJ P Fermand, Y Lévy, J Gerota, et al.
Blood|January 1, 1989
Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graftJ P Fermand, Y Levy, J Gerota, et al.
Blood|November 1, 1992
All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 casesP Fenaux, S Castaigne, H Dombret, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
[Autografts of blood cells at various stages]S Castaigne, L Dal Cortivo, G Leverger, et al.
Nouvelle Revue Francaise D'Hematologie|July 1, 1994
[Role of double induction in the treatment of acute myeloblastic leukemia in the adult: intermediate results of protocol LAM90]S Castaigne, E Archimbaud, P Fenaux, et al.
Blood|July 15, 1994
Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL GroupP Fenaux, E Wattel, E Archimbaud, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Prognostic factors of acute non lymphoblastic leukemia in children and adults. Results from two multicentric trials (705 patients)S Castaigne, S Chevret, E Lepage, et al.
Leukemia & Lymphoma|February 1, 1995
Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL GroupP Fenaux, C Chastang, C Chomienne, et al.
Haematology and Blood Transfusion|January 1, 1990
Comparison of chemotherapy and autologous and allogeneic transplantation as postinduction regimen in adult acute lymphoblastic leukemia: a preliminary multicentric studyD Fiere, A Broustet, V Leblond, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1987
Alpha-interferon in hairy cell leukaemia: direct effects on hairy cells or indirect cytotoxicity?F Sigaux, S Castaigne, P Lehn, et al.
Pageof 13